DELTEX Medical Group has appointed Jonathan Shaw as group finance director.
Shaw will become assume the post at the oesophageal Doppler monitoring specialist from 1 September 2015.
Shaw has experience with both accounting and auditing firms. Most notably, he has worked in senior directorial and managerial positions with both Grant Thornton and PwC in Southampton, where he was senior audit manager for Deltex.
Having undertaken several secondments during his career to industry and government, he spent three years at the Financial Reporting Council and nearly the same amount of time at the Financial Reporting Review Panel as a case officer.
A business mentor for The Prince’s Trust and a former director at BDO, Shaw is also a member of the Association of Chartered Certified Accountant’s Global Corporate Reporting Forum. He currently owns no shares in Deltex.
Deltex Medical’s chairman, Nigel Keen, said of the appointment: “We are delighted that Jonathan Shaw will join the Deltex board as group finance director.”
He added: “Jonathan knows our business well and has a wealth of management and financial reporting experience that will help us develop our business as we grow internationally.”